Abstract:Heart disease involves irreversible myocardial injury that leads to high morbidity and mortality rates. Numerous cell-based cardiac in vitro models have been proposed as complementary approaches to non-clinical animal research. However, most of these approaches struggle to accurately replicate adult human heart conditions, such as myocardial infarction and ventricular remodeling pathology. The intricate interplay between various cell types within the adult heart, including cardiomyocytes, fibroblasts, and endothelial cells, contributes to the complexity of most heart diseases. Consequently, the mechanisms behind heart disease induction cannot be attributed to a single-cell type. Thus, the use of multi-cellular models becomes essential for creating clinically relevant in vitro cell models. This study focuses on generating self-organizing heart organoids (HOs) using human-induced pluripotent stem cells (hiPSCs). These organoids consist of cardiomyocytes, fibroblasts, and endothelial cells, mimicking the cellular composition of the human heart. The multi-cellular composition of HOs was confirmed through various techniques, including immunohistochemistry, flow cytometry, q-PCR, and single-cell RNA sequencing. Subsequently, HOs were subjected to hypoxia-induced ischemia and ischemia-reperfusion (IR) injuries within controlled culture conditions. The resulting phenotypes resembled those of acute myocardial infarction (AMI), characterized by cardiac cell death, biomarker secretion, functional deficits, alterations in calcium ion handling, and changes in beating properties. Additionally, the HOs subjected to IR efficiently exhibited cardiac fibrosis, displaying collagen deposition, disrupted calcium ion handling, and electrophysiological anomalies that emulate heart disease. These findings hold significant implications for the advancement of in vivo-like 3D heart and disease modeling. These disease models present a promising alternative to animal experimentation for studying cardiac diseases, and they also serve as a platform for drug screening to identify potential therapeutic targets.

Cardiac Organoids: A 3D Technology for Disease Modeling and Drug Screening.

Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease

Cardiac Organoid — a Promising Perspective of Preclinical Model

Advances in Cardiac Organoids

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

Self-Assembled Chambered Cardiac Organoids for Modeling Cardiac Chamber Formation and Cardiotoxicity Assessment

Improving human cardiac organoid design using transcriptomics

Self-assembly vascularized human cardiac organoids model cardiac diseases in petri dishes and in mice

Generation of Human Vascularized and Chambered Cardiac Organoids for Cardiac Disease Modelling and Drug Evaluation.

Revolutionizing Cardiovascular Research: Human Organoids as a Beacon of Hope for Understanding and Treating Cardiovascular Diseases

Promises and Challenges of Cardiac Organoids

Longitudinal morphological and functional characterization of human heart organoids using optical coherence tomography

A Review of Protocols for Engineering Human Cardiac Organoids.

Engineering Cardiac Tissue for Advanced Heart‐on‐a‐chip Platforms

Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery

Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell-derived multi-cellular heart organoids

Engineered human cardiac tissues for modeling heart diseases

Generation of vascularized human cardiac organoids for 3D in vitro modeling

Single-cell Atlas of Multilineage Cardiac Organoids Derived from Human Induced Pluripotent Stem Cells

Unveiling New Horizons in Heart Research: the Promise of Multi-Chamber Cardiac Organoids

Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases